“Norton Healthcare is proud to be the first health care provider in Kentucky to offer this important new advance that can help increase screening for colon cancer,” said Thomas M. Woodcock, MD, an oncology specialist with Norton Cancer Institute, according to the report.
More articles on gastroenterology:
FDA approves generic version of GERD treatment drug
Gilead Sciences to allow drug makers to make generic version of HCV treatment Sovaldi
US Endoscopy releases new Roth Net polyp retriever
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.